Researchers at Queen’s have identified a number of biological targets, such as suicide genes in cells, which they hope will be stimulated by new drug compounds. Along with colleagues at Trinity, researchers at Queen's will design, synthesize and test the new compounds.
The funding for the cross-border project comes from Northern Ireland’s Department for Employment and Learning.
Professor Dennis McCance, Director of the Centre for Cancer Research and Cell Biology said: “Queen’s has expertise in identifying potential biological targets which could react to drug compounds. Our partners in Trinity are leaders in computational chemistry, whereby computers are used to design drugs given the structure of the target in the body.
“Therefore, putting our medicinal chemistry expertise along with Trinity’s expertise in computational chemistry will help ease a potential bottleneck in drug discovery across the island of Ireland, leading to new treatment options for those cancers with poor survival rates.”
The project is the first cross-border project of its type and will create in the region of 12 jobs initially. It is hoped that discoveries arising from the project will lead to spin-off companies and an increase in related jobs at pharmaceutical companies through the licensing of any new drugs.
The project is the latest in a round of projects at Queen’s to be awarded funding from the Department for Employment and Learning.
Earlier this month, the University received £7 million under the Cross-Border Research and Development Funding Programme.
The £7 million is being used to create five world-class research centres.
The centres will focus on the areas of next generation mobile networks, safety and traceability of agri-foods, diet and obesity, biomedical informatics research to accelerate drug discovery and identifying novel therapeutics of importance to many chronic diseases.
The centres will establish the island of Ireland as a significant force in addressing global challenges and indigenous industry and the all-ireland research base which will both be strengthened as a result of the investment.
Lisa Mitchell | alfa
Decision-making research in children: Rules of thumb are learned with time
19.10.2016 | Max-Planck-Institut für Bildungsforschung
Young people discover the "Learning Center"
20.09.2016 | Research Center Pharmaceutical Engineering GmbH
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering
06.12.2016 | Power and Electrical Engineering